G44A (p.Gly44Ala) variant of KRT3 (Keratin, type II cytoskeletal 3)

G44A (p.Gly44Ala) in KRT3 (Keratin, type II cytoskeletal 3) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as benign in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.36 / 1. The record also includes population frequency data and structural context.

G44A (p.Gly44Ala) variant details